ROCHE-M77001



A Multicenter, Randomized Comparative Study on the Efficacy and Safety of Herceptin (Trastuzumab) Plus Docetaxel (Taxotere) Versus Docetaxel Alone as First Line Treatment in Patients with HER2-Positive Metastatic Breast Cancer
trastuzumab
M77001
HER2-positive metastatic breast cancer
Phase 2
 
July 2015